European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Sapacitabine
| EU orphan designation number: | EU/3/08/557
|
| Active ingredient: | Sapacitabine |
| Indication: | Treatment of myelodysplastic syndromes |
| Sponsor: | Cyclacel Limited
Dundee Technopole, James Lindsay Place, Dundee DD1 5JJ, United Kingdom |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 10/07/2008 | Centralised Orphan - Designation | EMEA/OD/014/08 | (2008)3594 of 08/07/2008 |